Literature DB >> 3349399

Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica.

P E Shewen1, B N Wilkie.   

Abstract

In three experiments subcutaneous vaccination of calves with adjuvanted bacteria-free leukotoxic culture supernatant from log phase cultures of Pasteurella haemolytica A1 (toxin 1) was shown to induce some protection against intrabronchial challenge with live P. haemolytica A1. This toxin 1 vaccine was as effective as a whole cell bacterin in stimulating agglutinating antibody to P. haemolytica. Induction of leukotoxin neutralizing activity was variable; in some cases vaccination only primed the animal to produce an anamnestic response after challenge, whereas in other instances antitoxic activity increased in response to immunization. Two doses of vaccine were shown to be more effective than a single immunization. Vaccination with leukotoxic culture supernatant from the nonpathogenic P. haemolytica serotype 11 was as effective as vaccination with toxin 1 in stimulating antitoxic activity but was not protective. This implies that both serospecific agglutinating activity and an antitoxic response are needed for immunity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349399      PMCID: PMC1255396     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

1.  Pneumonic pasteurellosis of cattle: microbiology and immunology.

Authors:  R G Thomson; M L Benson; M Savan
Journal:  Can J Comp Med       Date:  1969-07

2.  Pasteurella haemolytica cytotoxin: production by recognized serotypes and neutralization by type-specific rabbit antisera.

Authors:  P E Shewen; B N Wilkie
Journal:  Am J Vet Res       Date:  1983-04       Impact factor: 1.156

3.  Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes.

Authors:  P E Shewen; B N Wilkie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

4.  Response of calves to lung challenge exposure with Pasteurella haemolytica after parenteral or pulmonary immunization.

Authors:  B N Wilkie; R J Markham; P E Shewen
Journal:  Am J Vet Res       Date:  1980-11       Impact factor: 1.156

5.  Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves.

Authors:  S C Friend; B N Wilkie; R G Thomson; D A Barnum
Journal:  Can J Comp Med       Date:  1977-01

6.  Factors associated with morbidity and mortality in feedlot calves: the Bruce County beef project, year two.

Authors:  S W Martin; A H Meek; D G Davis; J A Johnson; R A Curtis
Journal:  Can J Comp Med       Date:  1981-04

7.  The bovine alveolar macrophage. II. In vitro studies with Pasteurella haemolytica.

Authors:  M L Benson; R G Thomson; V E Valli
Journal:  Can J Comp Med       Date:  1978-07

8.  Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica.

Authors:  W D Yates; P H Stockdale; L A Babiuk; R J Smith
Journal:  Can J Comp Med       Date:  1983-07

9.  Factors associated with mortality in feedlot cattle: the Bruce County Beef Cattle Project.

Authors:  S W Martin; A H Meek; D G Davis; R G Thomson; J A Johnson; A Lopez; L Stephens; R A Curtis; J F Prescott; S Rosendal; M Savan; A J Zubaidy; M R Bolton
Journal:  Can J Comp Med       Date:  1980-01

10.  Antibody titers to Pasteurella haemolytica A1 in Ontario beef cattle.

Authors:  P E Shewen; B N Wilkie
Journal:  Can J Comp Med       Date:  1982-10
View more
  40 in total

1.  Author's reply.

Authors:  K G Bateman
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

2.  Efficacy of a Pasteurella haemolytica vaccine/bacterial extract.

Authors:  K W Jericho
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

3.  Molecular cloning of the Pasteurella haemolytica pomA gene and identification of bovine antibodies against PomA surface domains.

Authors:  H Zeng; K Pandher; G L Murphy
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis.

Authors:  D A Mosier; K R Simons; A W Confer; R J Panciera; K D Clinkenbeard
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

5.  Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1.

Authors:  K Pandher; A W Confer; G L Murphy
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1.

Authors:  R Y Lo; C A Strathdee; P E Shewen; B J Cooney
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  The association of titers to bovine coronavirus with treatment for bovine respiratory disease and weight gain in feedlot calves.

Authors:  S W Martin; E Nagy; P E Shewen; R J Harland
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

8.  The association of titers to Haemophilus somnus, and other putative pathogens, with the occurrence of bovine respiratory disease and weight gain in feedlot calves.

Authors:  S W Martin; R J Harland; K G Bateman; E Nagy
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

9.  Characterization of a 78-kilodalton outer membrane protein of Haemophilus somnus.

Authors:  S A Kania; R P Gogolewski; L B Corbeil
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  Characterization of immunodominant surface antigens of Haemophilus somnus.

Authors:  L B Corbeil; S A Kania; R P Gogolewski
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.